Strategy
MSTR
Coinbase
COIN
Tesla
TSLA
Vale SA
VALE
Salesforce
CRM
US Stock MarketDetailed Quotes
OSCR Oscar Health
- 14.650
- -0.880-5.67%
Close Mar 11 16:00 ET
- 14.920
- +0.270+1.84%
Post 18:54 ET
3.67BMarket Cap146.50P/E (TTM)
15.058High13.210Low8.96MVolume14.940Open15.530Pre Close127.75MTurnover4.39%Turnover Ratio146.50P/E (Static)250.57MShares23.79052wk High3.62P/B2.99BFloat Cap12.43052wk Low--Dividend TTM204.03MShs Float37.000Historical High--Div YieldTTM11.90%Amplitude2.050Historical Low14.264Avg Price1Lot Size
Oscar Health Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 459.42%978.19M | 16.83%346.82M | 56.48%-500.14M | 200.35%497.15M | 52.96%634.36M | -171.56%-272.16M | 96.09%296.87M | -109.58%-1.15B | -22.82%165.52M | -26.32%414.72M |
| Net income from continuing operations | 109.65%26.12M | -2.30%-153.29M | 17.22%-54.39M | 465.07%56.31M | 547.87%177.48M | 55.61%-270.59M | 33.86%-149.84M | 66.05%-65.7M | 86.24%-15.43M | 48.75%-39.63M |
| Operating gains losses | -132.86%-23K | ---25K | ---- | ---- | ---- | -94.51%70K | --0 | -91.98%61K | 54.05%-34K | -92.61%43K |
| Deferred tax | -4,131.03%-2.34M | -6,035.14%-2.27M | -272.46%-119K | -37.80%130K | 56.83%-79K | 135.15%58K | 78.36%-37K | 3,350.00%69K | 5,125.00%209K | ---183K |
| Other non cash items | -101.05%-300K | -92.78%1.2M | -113.51%-300K | -115.53%-200K | -111.78%-1M | 857.56%28.61M | --16.61M | --2.22M | --1.29M | 341.78%8.49M |
| Change in working capital | 536.71%838.86M | 17.70%473.84M | 57.40%-475.6M | 182.75%410.39M | 14.22%430.24M | -122.47%-192.09M | 17.10%402.57M | -186.73%-1.12B | -50.73%145.14M | -37.85%376.69M |
| -Change in receivables | -127.90%-177.52M | -228.24%-35.94M | 12.98%74.62M | -181.88%-63.71M | -132.84%-152.49M | 215.44%636.23M | 135.93%28.03M | 157.32%66.05M | 144.37%77.81M | 354.38%464.34M |
| -Change in loss and loss adjustment expense reserves | 1,282.77%390.74M | -99.99%4K | 90.91%104.5M | 103.95%3.88M | 1,627.08%282.36M | -93.34%28.26M | 195.70%55.54M | -52.50%54.74M | -182.52%-98.37M | -93.40%16.35M |
| -Change in payables and accrued expense | 174.09%634.49M | 60.24%499.38M | 46.78%-657.31M | 200.63%483.95M | 428.80%308.47M | -185.35%-856.36M | -34.36%311.64M | -216.74%-1.24B | -57.02%160.98M | -117.25%-93.82M |
| -Change in unearned premiums | 123.41%2.7M | 7,935.63%6.82M | 200.86%4.71M | -540.64%-7.02M | 67.86%-1.82M | 45.36%-11.52M | 98.74%-87K | -14.11%-4.67M | 83.27%-1.1M | -59.54%-5.66M |
| -Change in other current assets | -202.12%-11.55M | -51.97%3.58M | -183.05%-2.13M | -215.40%-6.72M | -38.86%-6.29M | 4,753.09%11.31M | -37.45%7.45M | -45.15%2.56M | 133.68%5.82M | -1,094.73%-4.53M |
| Cash from discontinued operating activities | ||||||||||
| Operating cash flow | 459.42%978.19M | 16.83%346.82M | 56.48%-500.14M | 200.35%497.15M | 52.96%634.36M | -171.56%-272.16M | 96.09%296.87M | -109.58%-1.15B | -22.82%165.52M | -26.32%414.72M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -340.38%-1.39B | -118.23%-31.45M | -356.44%-577.77M | -1,188.04%-477.63M | -321.82%-300.59M | 354.81%577.19M | 124.41%172.48M | -24.59%225.3M | -44.13%43.9M | 31.80%135.51M |
| Net investment purchase and sale | -325.35%-1.36B | -113.60%-24.62M | -347.75%-572.7M | -1,041.08%-470.89M | -306.64%-295.27M | 404.62%605.04M | 125.88%180.96M | -24.92%231.16M | -40.56%50.04M | 31.76%142.89M |
| Net PPE purchase and sale | -9.07%-27.9M | -11.75%-6.82M | -16.78%-7.57M | -34.63%-7.56M | 19.37%-5.95M | 11.84%-25.58M | 14.42%-6.1M | 32.63%-6.48M | 6.66%-5.62M | -18.12%-7.38M |
| Net other investing changes | 272.55%3.93M | 99.45%-13K | 300.48%2.49M | --825K | --626K | -304.03%-2.28M | -450.23%-2.38M | 18.48%622K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -340.38%-1.39B | -118.23%-31.45M | -356.44%-577.77M | -1,188.04%-477.63M | -321.82%-300.59M | 354.81%577.19M | 124.41%172.48M | -24.59%225.3M | -44.13%43.9M | 31.80%135.51M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 960.94%68.39M | 257.06%3.82M | 700.00%18.56M | 633.12%18.7M | 5,297.04%27.31M | -97.86%6.45M | 102.85%1.07M | 448.46%2.32M | 84.19%2.55M | -99.83%506K |
| Net issuance payments of debt | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | 1,628.72%68.39M | 256.73%3.82M | 6,086.67%18.56M | 633.12%18.7M | 77,925.71%27.31M | 204.54%3.96M | 21,300.00%1.07M | -18.92%300K | 600.82%2.55M | -93.75%35K |
| Net other financing charges | ---- | ---- | ---- | ---- | ---- | 147.99%2.49M | -100.19%-1K | 3,711.32%2.02M | --0 | 106.94%471K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 960.94%68.39M | 257.06%3.82M | 700.00%18.56M | 633.12%18.7M | 5,297.04%27.31M | -97.86%6.45M | 102.85%1.07M | 448.46%2.32M | 84.19%2.55M | -99.83%506K |
| Net cash flow | ||||||||||
| Beginning cash position | 19.71%1.89B | -13.34%1.23B | -2.22%2.29B | 5.72%2.25B | 19.71%1.89B | 40.42%1.58B | -33.42%1.42B | -1.73%2.34B | 1.97%2.13B | 40.42%1.58B |
| Current changes in cash | -209.43%-340.85M | -32.15%319.19M | -14.94%-1.06B | -81.97%38.23M | -34.44%361.08M | -31.54%311.47M | 184.80%470.41M | -269.89%-921.64M | -28.01%211.97M | -42.90%550.73M |
| End cash position | -18.02%1.55B | -18.02%1.55B | -13.34%1.23B | -2.22%2.29B | 5.72%2.25B | 19.71%1.89B | 19.71%1.89B | -33.42%1.42B | -1.73%2.34B | 1.97%2.13B |
| Free cash flow | 419.17%950.3M | 16.93%340M | 56.07%-507.71M | 206.17%489.59M | 54.27%628.41M | -184.74%-297.74M | 101.55%290.77M | -107.13%-1.16B | -23.29%159.91M | -26.82%407.34M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.